Literature DB >> 31278881

Enhanced generation of intraluminal vesicles in neuronal late endosomes in the brain of a Down syndrome mouse model with endosomal dysfunction.

Pasquale D'Acunzo1,2, Tal Hargash1, Monika Pawlik1, Chris N Goulbourne1, Rocío Pérez-González1,2, Efrat Levy1,2,3,4.   

Abstract

Down syndrome (DS) is a human genetic disease caused by trisomy of chromosome 21 and characterized by early developmental brain abnormalities. Dysfunctional endosomal pathway in neurons is an early event of DS and Alzheimer's disease. Recently, we have demonstrated that exosome secretion is upregulated in human DS postmortem brains, in the brain of the trisomic mouse model Ts[Rb(12.1716 )]2Cje (Ts2) and by DS fibroblasts as compared with disomic controls. High levels of the tetraspanin CD63, a regulator of exosome biogenesis, were observed in DS brains. Partially blocking exosome secretion by DS fibroblasts exacerbated a pre-existing early endosomal pathology. We thus hypothesized that enhanced CD63 expression induces generation of intraluminal vesicles (ILVs) in late endosomes/multivesicular bodies (MVBs), increasing exosome release as an endogenous mechanism to mitigate endosomal abnormalities in DS. Herein, we show a high-resolution electron microscopy analysis of MVBs in neurons of the frontal cortex of 12-month-old Ts2 mice and littermate diploid controls. Our quantitative analysis revealed that Ts2 MVBs are larger, more abundant, and contain a higher number of ILVs per neuron compared to controls. These findings were further corroborated biochemically by Western blot analysis of purified endosomal fractions showing higher levels of ILVs proteins in the same fractions containing endosomal markers in the brain of Ts2 mice compared to controls. These data suggest that upregulation of ILVs production may be a key homeostatic mechanism to alleviate endosomal dysregulation via the endosomal-exosomal pathway.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; CD63; Down syndrome; exosome; extracellular vesicles

Mesh:

Year:  2019        PMID: 31278881      PMCID: PMC6894426          DOI: 10.1002/dneu.22708

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  28 in total

Review 1.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

2.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

3.  Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12.

Authors:  Angela J Villar; Pavel V Belichenko; Anne Marie Gillespie; Heather M Kozy; William C Mobley; Charles J Epstein
Journal:  Mamm Genome       Date:  2005-02       Impact factor: 2.957

4.  App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.

Authors:  Anne M Cataldo; Suzana Petanceska; Corrinne M Peterhoff; Nicole B Terio; Charles J Epstein; Angela Villar; Elaine J Carlson; Matthias Staufenbiel; Ralph A Nixon
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

5.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

Authors:  K E Wisniewski; H M Wisniewski; G Y Wen
Journal:  Ann Neurol       Date:  1985-03       Impact factor: 10.422

6.  Ceramide triggers budding of exosome vesicles into multivesicular endosomes.

Authors:  Katarina Trajkovic; Chieh Hsu; Salvatore Chiantia; Lawrence Rajendran; Dirk Wenzel; Felix Wieland; Petra Schwille; Britta Brügger; Mikael Simons
Journal:  Science       Date:  2008-02-29       Impact factor: 47.728

Review 7.  Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease.

Authors:  Daniel J Colacurcio; Anna Pensalfini; Ying Jiang; Ralph A Nixon
Journal:  Free Radic Biol Med       Date:  2017-10-06       Impact factor: 7.376

8.  Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease.

Authors:  Seymour Levine; Arthur Saltzman; Efrat Levy; Stephen D Ginsberg
Journal:  Exp Mol Pathol       Date:  2008-11-07       Impact factor: 3.362

9.  Apolipoprotein E4 genotype compromises brain exosome production.

Authors:  Katherine Y Peng; Rocío Pérez-González; Melissa J Alldred; Chris N Goulbourne; Jose Morales-Corraliza; Mariko Saito; Mitsuo Saito; Stephen D Ginsberg; Paul M Mathews; Efrat Levy
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

10.  Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities.

Authors:  Sébastien A Gauthier; Rocío Pérez-González; Ajay Sharma; Fang-Ke Huang; Melissa J Alldred; Monika Pawlik; Gurjinder Kaur; Stephen D Ginsberg; Thomas A Neubert; Efrat Levy
Journal:  Acta Neuropathol Commun       Date:  2017-08-29       Impact factor: 7.801

View more
  14 in total

Review 1.  Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues.

Authors:  Pasquale D'Acunzo; Yohan Kim; Jonathan M Ungania; Rocío Pérez-González; Chris N Goulbourne; Efrat Levy
Journal:  Nat Protoc       Date:  2022-08-12       Impact factor: 17.021

Review 2.  Exosome Production Is Key to Neuronal Endosomal Pathway Integrity in Neurodegenerative Diseases.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Front Neurosci       Date:  2019-12-12       Impact factor: 4.677

Review 3.  The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma.

Authors:  Xueying Wang; Junnan Guo; Pingyang Yu; Lunhua Guo; Xionghui Mao; Junrong Wang; Susheng Miao; Ji Sun
Journal:  J Exp Clin Cancer Res       Date:  2021-01-21

4.  Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome.

Authors:  Pasquale D'Acunzo; Rocío Pérez-González; Yohan Kim; Tal Hargash; Chelsea Miller; Melissa J Alldred; Hediye Erdjument-Bromage; Sai C Penikalapati; Monika Pawlik; Mitsuo Saito; Mariko Saito; Stephen D Ginsberg; Thomas A Neubert; Chris N Goulbourne; Efrat Levy
Journal:  Sci Adv       Date:  2021-02-12       Impact factor: 14.136

5.  Cerebellar Kv3.3 potassium channels activate TANK-binding kinase 1 to regulate trafficking of the cell survival protein Hax-1.

Authors:  Yalan Zhang; Luis Varela; Klara Szigeti-Buck; Adam Williams; Milan Stoiljkovic; Matija Šestan-Peša; Jorge Henao-Mejia; Pasquale D'Acunzo; Efrat Levy; Richard A Flavell; Tamas L Horvath; Leonard K Kaczmarek
Journal:  Nat Commun       Date:  2021-03-19       Impact factor: 17.694

Review 6.  Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration.

Authors:  Ricardo Quiroz-Baez; Karina Hernández-Ortega; Eduardo Martínez-Martínez
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

7.  Extracellular vesicles: where the amyloid precursor protein carboxyl-terminal fragments accumulate and amyloid-β oligomerizes.

Authors:  Rocío Pérez-González; Yohan Kim; Chelsea Miller; Javier Pacheco-Quinto; Elizabeth A Eckman; Efrat Levy
Journal:  FASEB J       Date:  2020-08-09       Impact factor: 5.191

Review 8.  Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.

Authors:  Xuan T T Dang; Jayasinghe Migara Kavishka; Daniel Xin Zhang; Marco Pirisinu; Minh T N Le
Journal:  Cells       Date:  2020-09-29       Impact factor: 6.600

9.  Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients.

Authors:  Andrew E Arrant; Skylar E Davis; Rachael M Vollmer; Charles F Murchison; James A Mobley; Alissa L Nana; Salvatore Spina; Lea T Grinberg; Anna M Karydas; Bruce L Miller; William W Seeley; Erik D Roberson
Journal:  Ann Clin Transl Neurol       Date:  2020-11-16       Impact factor: 5.430

10.  Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome.

Authors:  Xu-Qiao Chen; Zhuo Xing; Quang-Di Chen; Richard J Salvi; Xuming Zhang; Benjamin Tycko; William C Mobley; Y Eugene Yu
Journal:  Front Aging Neurosci       Date:  2021-07-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.